US starts up register of biocontrol agent companies
This article was originally published in Clinica
Companies in possession of biological agents will have to register with the Centers for Disease Control and Prevention (CDC), as of February 7 2003. Previously companies only had to register when the material left their possession.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.